UK’s NICE Backs Interim Funding For 14-Day Ambulatory Heart Monitoring Tech
Executive Summary
Health technology assessment body says that while iRhythm Technologies’ Zio XT service improves cardiac arrhythmia detection, more data must be collected to address evidence gaps about its benefit.
You may also be interested in...
Reimbursement For Long-Term Cardiac Monitoring Remains Uncertain, iRhythm Reports
Local Medicare carrier Novitas met with monitoring companies to discuss rates for long-term ECG monitoring, but no final decision on recently proposed rate cuts has been reached, iRhythm reported.
Cardiac Monitoring Companies Fight Medicare Reimbursement Cut By Novitas
Medicare carrier Novitas has proposed to cut reimbursement for long-term electrocardiogram monitoring, which could be a major headache for companies like iRhythm.
AI Tops The Tech Priorities For UK NHS With New Govt Funding Pledge
With health care in the UK being increasingly restructured around digital delivery, bodies like the new NHSX, NHS Digital and the forthcoming Digital Innovation Hubs will be in the forefront of health-care policy-making at the national level. A new government funding pledge has underlined the importance of taking the opportunities that artificial intelligence, machine learning and genomic medicine offer in health care.